Advertisement
| dual antiplatelet therapy guidelines 2021: Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease Sorin Brener, 2021-01-26 Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease is a complete reference containing updated information on the advantages and disadvantages of dual antiplatelet therapy, its duration, composition and anticipated changes. The basis for DAPT in arterial disease is discussed, allowing readers to understand platelet physiology and its relevance to ischemic events. Data on shorter than usual duration of DAPT, and on extended therapy beyond the recommendation of current guidelines is presented in great detail, summarizing a large body of evidence into concrete, relevant recommendation that is readily adaptable by practicing clinicians. A clinically relevant and updated compendium of data pertaining to this field is also presented, as well as the anticipated trends and innovations likely to occur in the next 3-5 years. Summarizes a large body of evidence into concrete, relevant recommendations that is readily adapted by practicing clinicians Explores the current status of DAPT, controversial topics, and future developments and trends in this field Edited and contributed by renowned cardiologists in the field |
| dual antiplatelet therapy guidelines 2021: Antithrombotic Therapy Richard C. Becker, Dan J. Fintel, David Green, 2010-12-31 Clinical application of antithrombotic therapy in both arterial disease (acute coronary syndromes, acute MI, peripheral arterial disease, valvular heart disease, atrial fibrillation) and venous disease, (venous thromboembolic disease and pulmonary embolism). Results of major clinical trials and their implications for clinical practice. |
| dual antiplatelet therapy guidelines 2021: Practical Manual of Interventional Cardiology Annapoorna Kini, Samin Sharma, Jagat Narula, 2014-11-26 This practical handbook is based on an internal working manual developed by staff and fellows at Mount Sinai Heart Cardiovascular Catheterization Laboratory, renowned for its high-volume and low complication complex coronary procedures. The Practical Handbook of Interventional Cardiology captures the knowledge and methodological know-how from leaders in interventional cardiology, it intends to guide users in a stepwise, methodical and practical approach through various cardiac interventional procedures in order to achieve maximum patient safety and improved outcomes. From patient selection, preoperative work-up, setting up equipment to step-by-step illustrations of various procedural details and troubleshooting, this handbook captures all the details necessary to perform the simplest to the most complex cardiac interventions. The book is designed for cardiologists and trainees who desire an efficient way to review the steps of various cardiac interventional procedures and a quick, reliable reference for everyday use. |
| dual antiplatelet therapy guidelines 2021: Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs American Association of Cardiovascular & Pulmonary Rehabilitation, 2004 This edition addresses the cost effectiveness of interventions that educate and motivate patients to assume personal responsibility for long-term disease prevention. |
| dual antiplatelet therapy guidelines 2021: Bioresorbable Scaffolds Yoshinobu Onuma, Patrick W.J.C. Serruys, 2017-10-02 This book focuses on the coronary bioresorbable scaffold, a new interventional treatment for coronary artery disease, differentiated from a permanent metallic stent. The book provides an overview of the technology including non-clinical studies and clinical evidences in order to help clinicians understand the appropriate application of the technology and the optimal techniques of implantation. It covers the basics of bioresorbable scaffolds; bench test results; preclinical studies; clinical evidences; and tips and tricks of implantation. |
| dual antiplatelet therapy guidelines 2021: Cerebral Small Vessel Disease Leonardo Pantoni, Philip B. Gorelick, 2014-05 Up-to-date discussion of the etiology, diagnosis, treatment, and prevention of this common cause of stroke and cognitive impairment. |
| dual antiplatelet therapy guidelines 2021: Prevention of Stroke John W. Norris, Vladimir C. Hachinski, 2013-06-29 Prevention of Stroke sums up and critically analyzes our present knowledge and understanding of all major aspects of stroke prophylaxis, medical and surgical. The book is intended for not only neurologists and neurosurgeons directly involved with stroke patients, but also vascular surgeons, internists, family physicians, and health planners. Topics explored include the cellular basis of atherosclerosis; stroke risk factors; head and neck bruits in stroke prevention; the present status of anticoagulant prophylaxis; hypertension and stroke prevention; and prevention of cardioembolic stroke, as well as the efficacy of aspirin and of ticlopidine in stroke prevention. Surgical prophylaxis is examined through discussions of carotid endarterectomy, prevention of stroke from cerebral vascular malformations, prevention of aneurysmal subarachnoid hemorrhage, balloon transluminal angioplasty of the carotid artery in the head and neck, and prevention of recurrent stroke. |
| dual antiplatelet therapy guidelines 2021: Primary Angioplasty Timothy J Watson, Paul JL Ong, James E Tcheng, 2018-07-13 This book is open access under a CC BY 4.0 license. This quick-reference handbook offers a concise and practical review of key aspects of the treatment of ST-segment elevation myocardial infarction (STEMI) in the era of primary percutaneous coronary intervention (PPCI). In the context of STEMI, PPCI is the preferred mode of emergency revascularization. Access to PPCI is rapidly increasing and is now routinely practiced in both general and specialist hospitals and there has been a recent emphasis on developing STEMI networks to enhance and expedite the referral pathway. This coupled with concurrent developments to enhance the safety and efficacy of the PPCI procedure has heralded an era where STEMI interventions are increasingly considered an important subspecialty within interventional cardiology. Written by leading cardiologists who have been instrumental in the adoption of PPCI in their respective institutions, the book provides junior and senior cardiologists alike with insightful and thought-provoking tips and tricks to enhance the success of PPCI procedures, which may in turn translate into direct improvements in outcomes. The book is also relevant for healthcare providers and emergency department physicians. |
| dual antiplatelet therapy guidelines 2021: Anticoagulation Therapy Joe F. Lau, Geoffrey D. Barnes, Michael B. Streiff, 2018-04-16 This book presents the latest evidence and guidelines supporting the use of anticoagulant therapy for various clinical scenarios. The field of anticoagulation therapy is evolving rapidly, particularly since the arrival and widespread adoption of direct oral anticoagulants. Organized in two parts, this book reviews the pharmacologic properties of various anticoagulants and details the clinical applications of anticoagulant therapy. Drugs such as warfarin and unfractionated heparin, as well as parenteral and direct oral anticoagulants are discussed in terms of their pharmacokinetics, drug-disease interactions, dosing strategies, and risk considerations. Clinical applications of anticoagulant therapy in disorders such as acute coronary syndromes, atrial fibrillation, and thrombophilia and in special populations such as pregnant women, the elderly, and in the patient with cancer are highlighted. Clinical vignettes, algorithms, clinical pearls, and self-assessment questions are integrated throughout the book. Featuring contributions from authorities in the field, Anticoagulation Therapy is an essential resource for cardiologists, vascular medicine specialists, hematologists, internists, and all other healthcare professionals who prescribe anticoagulants. |
| dual antiplatelet therapy guidelines 2021: Antiplatelet Therapy in Cardiovascular Disease Ron Waksman, Paul A. Gurbel, Michael A. Gaglia, Jr., 2014-03-24 Edited by a team of the world’s leading interventional cardiologists and educators, this new book is created with an eye to giving the reader a solid, practical, and clinically focused understanding of this important class of drugs, from basic science to a clear-headed discussion of complex topics such as combination therapies, drug-to-drug interactions, and resistance to antiplatelet agents. This important new book: Begins with a concise but thorough discussion of platelet biology and pathophysiology so that readers understand how antiplatelet agents work and why they produce such a varied range of complications, from minor GI upset to potentially life-threatening conditions such as neutropenia, a critical shortage of white blood cells. Thoroughly covers platelet function testing, including novel techniques. Clarifies current best practice regarding the use of antiplatelet agents in both chronic and acute cardiovascular disease. Reviews all types of antiplatelet agents – from aspirin to recently approved drugs – including indications, clinical outcomes, and side effects. Written by an international “who’s who” of experts in the field, Antiplatelet Therapy in Cardiovascular Disease also includes an entire section covering the use of antiplatelet drugs in PCIs, including percutaneous valve repair, which makes this text particularly essential to interventional cardiologists. |
| dual antiplatelet therapy guidelines 2021: Finding What Works in Health Care Institute of Medicine, Board on Health Care Services, Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, 2011-07-20 Healthcare decision makers in search of reliable information that compares health interventions increasingly turn to systematic reviews for the best summary of the evidence. Systematic reviews identify, select, assess, and synthesize the findings of similar but separate studies, and can help clarify what is known and not known about the potential benefits and harms of drugs, devices, and other healthcare services. Systematic reviews can be helpful for clinicians who want to integrate research findings into their daily practices, for patients to make well-informed choices about their own care, for professional medical societies and other organizations that develop clinical practice guidelines. Too often systematic reviews are of uncertain or poor quality. There are no universally accepted standards for developing systematic reviews leading to variability in how conflicts of interest and biases are handled, how evidence is appraised, and the overall scientific rigor of the process. In Finding What Works in Health Care the Institute of Medicine (IOM) recommends 21 standards for developing high-quality systematic reviews of comparative effectiveness research. The standards address the entire systematic review process from the initial steps of formulating the topic and building the review team to producing a detailed final report that synthesizes what the evidence shows and where knowledge gaps remain. Finding What Works in Health Care also proposes a framework for improving the quality of the science underpinning systematic reviews. This book will serve as a vital resource for both sponsors and producers of systematic reviews of comparative effectiveness research. |
| dual antiplatelet therapy guidelines 2021: Treating Tobacco Use and Dependence: 2008 Update: Clinical Practice Guideline , 2009 |
| dual antiplatelet therapy guidelines 2021: Antiplatelet and Anticoagulation Therapy Albert Ferro, David A. Garcia, 2012-10-13 This title will be presented as highly practical information pn pharmaceutical antiplatelet and anticoagulation therapy, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose. The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series. Each volume is designed to be between 120 and 250 pages containing practical illustrations and designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas. |
| dual antiplatelet therapy guidelines 2021: Carotid Interventions Peter Schneider, Todd Bohannon, Michael Silva, 2004-08-30 From patient selection and monitoring to follow-up care, Carotid Interventions is the first source to offer a practical how-to approach to carotid angioplasty and stenting-providing maneuvers and strategies for difficult situations, as well as step-by-step guidance on specific surgical procedures, equipment selection and instrumentation, protection |
| dual antiplatelet therapy guidelines 2021: Network Meta-analysis Giuseppe Biondi-Zoccai, 2014 Network meta-analyses and mixed treatment comparisons represent the uppermost level in the evidence hierarchy for decision making, in medicine as well as in other scholarly fields. This book covers the main topics which should be mastered to critically read and interpret as well as, if deemed worthwhile, perform and report independently a network meta-analysis and mixed treatment comparison. The text includes dozens of tables and illustrations to guide visually the reader in understanding the basics as well as the more refined details of network meta-analyses. |
| dual antiplatelet therapy guidelines 2021: Management of Acute Pulmonary Embolism Stavros V. Konstantinides, 2007-12-31 This practical volume highlights traditional, novel, and evolving aspects of the diagnosis and treatment of pulmonary embolism (PE). The contributors comprise an international team of experts. Important aspects of diagnosis, risk stratification, and differential treatment of patients with PE are presented in a concise, yet comprehensive manner. Emphasis is placed on specific issues related to PE, including pregnancy, cancer, thrombophilia, and air travel. |
| dual antiplatelet therapy guidelines 2021: Gastroenterological Endoscopy Michael B. Wallace, Paul Fockens, Joseph Jao-Yiu Sung, 2018-01-24 Praise for the previous edition: Extraordinary achievement … this volume stands on its own as a marvelous feat in bringing such a vast array of clear and coherent instruction to endoscopists at all skill levels.—Gastroenterology Written and edited by internationally renowned specialists, the third edition of Gastroenterological Endoscopy covers the entire spectrum of diagnostic and therapeutic procedures for the upper and lower GI tract while providing the latest overview of GI disorders. A great wealth of high-resolution photographs provides the visual information needed to confidently assess and diagnose mucosal lesions of the entire digestive tract. Significant advances in the field—both medical and technical—since the last edition are covered in comprehensive detail. Key Features: New panel of top international editors, continuing the tradition of excellence, depth, and breadth as originated by founding editors Classen, Tytgat, and Lightdale; list of contributing authors is a who's who of GI endoscopy Coverage of newest, advanced tools and techniques: gastric-POEMS, submucosal tunnel endoscopic resection (STER), lumen-apposing metal stents, over-the-scope clips, and much more More than 1,500 exquisite images Gastroenterological Endoscopy, third edition, surely deserves a prominent place in any complete endoscopy reference collection. Michael B. Wallace, MD, is Professor of Medicine at the Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA Paul Fockens, MD, is Professor and Chair of the Dept. of Gastroenterology and Hepatology at the Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands Joseph Jao-Yiu Sung, MD, PhD, is Mok Hing Yiu Professor of Medicine and Director of the Institute of Digestive Diseases of The Chinese University of Hong Kong, Shatin, Hong Kong An award-winning international medical and scientific publisher, Thieme has demonstrated its commitment to the highest standard of quality in the state-of-the-art content and presentation of all its products. Founded in 1886, the Thieme name has become synonymous with high quality and excellence in online and print publishing. |
| dual antiplatelet therapy guidelines 2021: Clinical Practice Guidelines We Can Trust Institute of Medicine, Board on Health Care Services, Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, 2011-06-16 Advances in medical, biomedical and health services research have reduced the level of uncertainty in clinical practice. Clinical practice guidelines (CPGs) complement this progress by establishing standards of care backed by strong scientific evidence. CPGs are statements that include recommendations intended to optimize patient care. These statements are informed by a systematic review of evidence and an assessment of the benefits and costs of alternative care options. Clinical Practice Guidelines We Can Trust examines the current state of clinical practice guidelines and how they can be improved to enhance healthcare quality and patient outcomes. Clinical practice guidelines now are ubiquitous in our healthcare system. The Guidelines International Network (GIN) database currently lists more than 3,700 guidelines from 39 countries. Developing guidelines presents a number of challenges including lack of transparent methodological practices, difficulty reconciling conflicting guidelines, and conflicts of interest. Clinical Practice Guidelines We Can Trust explores questions surrounding the quality of CPG development processes and the establishment of standards. It proposes eight standards for developing trustworthy clinical practice guidelines emphasizing transparency; management of conflict of interest ; systematic review-guideline development intersection; establishing evidence foundations for and rating strength of guideline recommendations; articulation of recommendations; external review; and updating. Clinical Practice Guidelines We Can Trust shows how clinical practice guidelines can enhance clinician and patient decision-making by translating complex scientific research findings into recommendations for clinical practice that are relevant to the individual patient encounter, instead of implementing a one size fits all approach to patient care. This book contains information directly related to the work of the Agency for Healthcare Research and Quality (AHRQ), as well as various Congressional staff and policymakers. It is a vital resource for medical specialty societies, disease advocacy groups, health professionals, private and international organizations that develop or use clinical practice guidelines, consumers, clinicians, and payers. |
| dual antiplatelet therapy guidelines 2021: ASPC Manual of Preventive Cardiology Ezra A. Amsterdam, Nathan Wong, Ezra Amsterdam, MD, Roger Blumenthal, MD, FACC, FAHA, 2014-10-23 Endorsed by the American Society for Preventive Cardiology, this highly practical resource focuses on the application of current guidelines and practice standards in the clinical management of cardiovascular risk factors. The Manual presents concise descriptions of each major cardiovascular risk factor, and practical, to-the-point discussions of current best practices in clinical management. In addition, the Manual includes chapters on peripheral arterial disease, stroke, smoking, contemporary cardiovascular imaging, heart failure, metabolic syndrome, thrombosis, nutrition, special populations, novel risk factors, and psychosocial stress. Throughout the Manual, recommendations are based on the most recent prevention guidelines of the American College of Cardiology and American Heart Association, including those on Risk Assessment, Lifestyle Recommendations, Blood Cholesterol, and Obesity, as well as the new guidelines on Hypertension. Chapter authors are recognized leaders in each area of practice, and special efforts have been made by the authors and editors to ensure that the content of all chapters is as up-to-date as possible. Key Features: Presents a highly practical focus on the application of current guidelines and practice standards regarding cardiovascular risk factors Recommendations based on the most recent prevention guidelines Authored by recognized leaders in the field Covers all major cardiovascular risk factors, key methodologies in risk assessment, and special issues regarding specific patient populations |
| dual antiplatelet therapy guidelines 2021: Cardiovascular Thrombus On Topaz, 2018-08-18 Cardiovascular Thrombus: From Pathology and Clinical Presentations to Imaging, Pharmacotherapy and Interventions provides a comprehensive, up-to-date presentation of the research and clinical practices as related to the contemporary aspects of the diagnosis and management of cardiovascular thrombosis. The formation, identification and management of cardiovascular thrombus is of paramount importance for researchers and practicing physicians, yet it remains one of the most challenging diagnostic and clinical scenarios. This important reference connects between research, up-to-date clinical knowledge, and the technological tools available for diagnosis and management of thrombus in cardiovascular medicine. The book includes comprehensive descriptions and review of pathology, clinical presentations, diagnosis, pharmacotherapy, interventions and future trends. It is the perfect reference for basic science students and researchers in general and interventional cardiology, general and interventional radiology, vascular medicine specialists, and vascular, general and cardiac surgeons. Provides comprehensive presentation of the pathophysiology, clinical presentations and diagnosis of cardiovascular thrombosis Includes the most up-to-date information on the practical management of patients with thrombus related conditions Written by the leading experts in the field Describes the current and upcoming pharmacotherapy and technology available for thrombus research and treatment |
| dual antiplatelet therapy guidelines 2021: Atrial Fibrillation and Percutaneous Coronary Intervention Andrea Rubboli, Gregory Y. H. Lip, 2016-11-30 This book considers paradigmatic clinical cases in order to cast light on key issues relating to elective or emergency stent implantation and the use of oral anticoagulation (OAC) in patients with atrial fibrillation. The topics addressed include the optimal periprocedural antithrombotic treatment (uninterrupted vs interrupted OAC, intraprocedural use of heparin and glycoprotein IIb/IIIa inhibitors, etc.), the most appropriate type of stent (bare metal vs drug eluting vs “bioactive”), the optimal regimen (e.g., triple therapy of OAC, aspirin, and clopidogrel vs the combination of OAC and a single antiplatelet agent), and the most suitable duration of the antithrombotic treatment prescribed at discharge (1 vs 6–12 months). The case-based management recommendations will be of wide practical value in the current health care context, where percutaneous coronary intervention is available even to patients with relevant co-morbidities, such as those warranting long-term OAC, and the indications for OAC are much broader than in the past. The book will appeal especially to clinical and interventional cardiologists, internal medicine specialists, hematologists, and family physicians and will also be of interest to cardiology and internal medicine residents and fellows. |
| dual antiplatelet therapy guidelines 2021: Flexible Bronchoscopy Ko-Pen Wang, Atul C. Mehta, J. Francis Turner, Jr., 2020-07-13 In this fourth edition of the popular Flexible Bronchoscopy, which has been revised and updated throughout, the world's leading specialists discuss the technical and procedural aspects of performing diagnostic and therapeutic bronchoscopy. Four new chapters have been added, taking into account new developments in EBUS and electromagnetic navigation. |
| dual antiplatelet therapy guidelines 2021: Antiplatelet Therapy in ACS and A-Fib Victor L. Serebruany, Dan Atar, 2012 Written by top experts in the field Platelets play a critical role in the pathophysiology of acute coronary syndromes (ACS) and thromboembolic complications associated with atrial fibrillation. Anticoagulant and antiplatelet therapies are central to the treatment of ACS and atrial fibrillation. Over the last several decades, a better understanding of the pathogenesis of coronary heart disease and atrial fibrillation has led to refinements in antithrombotic strategies and clinical outcomes. With this in mind, some of the issues outlined in this book are new insights in genetic testing and modification of individualized antiplatelet therapy based on rapid bedside platelet analyzers. Most importantly, the current update of pros and cons of novel antiplatelet agents such as prasugrel and ticagrelor are provided in detail. Conventional antiplatelet strategies with aspirin and clopidogrel are also discussed. Special attention is devoted to experimental antiplatelet agents like PAR-1 thrombin receptor antagonists or aptamers. The ability to focus on different diseases beyond ACS, including heart failure and atrial fibrillation, distinguishes this publication. Each chapter was written by top experts in the field and scientists with the utmost authority and expertise to provide cardiologists, internists, and clinical pharmacologists with the latest updates. |
| dual antiplatelet therapy guidelines 2021: Stroke-Vascular Diseases W.Wolfgang Fleischhacker, David J. Brooks, 2002-11-07 Atherosclerosis, the underlying cause of heart attacks, strokes and peripheral vascular disease, is one of the major killers in the world. By 2020 WHO statistics indicate that it will be the most common cause of morbidity and mortality in both the industrialised world and the underdeveloped world. The disease develops slowly over many years in the innermost layer of large and medium-sized arteries (Fig. 1) (Scott, 1995; Ross, 1999; Naumova and Scott, 2000; Glass and Witztum, 2001; Libby, 2001). It does not usually become manifest before the fourth of fifth decade, but then often strikes with devas tating suddenness. Fifty per cent of individuals still die (25 per cent immedi ately) from their first heart attack; and morbidity from coronary heart disease and stroke is very significant. The disease has a profound impact on health care services and on industrial economies. The lesions of atherosclerosis Autopsy studies show that in humans atherosclerosis begins in the first and second decade of life. A similar disease can be produced in experimental animals, where diet and genetics can be manipulated to produce identical lesions. The earliest lesions are fatty streaks. These consist of an accumulation of lipid-engorged macrophages (foam cells) and T and B lymphocytes in the arterial intima. With time, the fatty streaks progress to intermediate lesions, composed of foam cells and smooth muscle cells. |
| dual antiplatelet therapy guidelines 2021: The ESC Textbook of Cardiovascular Medicine A. John Camm, 2019 |
| dual antiplatelet therapy guidelines 2021: Percutaneous Revascularization Techniques Manuel Maynar-Moliner, 1993 |
| dual antiplatelet therapy guidelines 2021: Textbook of Interventional Cardiology Eric J. Topol, 1994 The 4th Edition of this respected resource provides comprehensive, detailed, up-to-date, and clinically oriented coverage of all aspects of percutaneous coronary revascularization. More than 68 leaders in the field offer practical, evidence-based guidance on treating a full range of coronary lesions. They discuss the very latest techniques, devices, and adjunctive therapies, and offer critical appraisals of emerging therapeutic approaches. |
| dual antiplatelet therapy guidelines 2021: Blood Conservation in Cardiac Surgery Karl H. Krieger, O. Wayne Isom, 2012-12-06 Here, two of the foremost cardiothoracic surgeons have brought together many of the top cardiologists and haematologists to produce the most current reference source on all aspects of blood conservation, from an overall clinical approach to the use of erythropoietin and the benefits of post-operative blood salvage. The subject matter covers numerous areas involved in the preoperative considerations in cardiac surgery, the intraoperative decision-making in cardiac surgery, postoperative bleeding and management and a section on the algorithm for bloodless surgery used at the New York Hospital-Cornell Medical Center. |
| dual antiplatelet therapy guidelines 2021: Moyamoya Disease Vicente Vanaclocha, 2021 Moyamoya disease is a rare cerebrovascular disease most prevalent in East Asian countries. Thanks to new diagnostic capabilities, the number of cases discovered, including asymptomatic patients, has been increasing steadily. However, asymptomatic from the clinical point of view does not necessarily mean that there are no subjacent problems. Indeed, many patients harbour cognitive decline long before they exhibit clinical or radiological manifestations. The only effective treatment is surgical revascularization, either direct, indirect, or combined. Many posit that preventive surgical treatment should be considered even in asymptomatic moyamoya patients, particularly in the paediatric age group. This book expands on these ideas and examines the various aspects of this dreadful disease. |
| dual antiplatelet therapy guidelines 2021: Drug-Coated Balloons Bernardo Cortese, 2019-06-19 This book provides a comprehensive, up-to-date summary of drug-coated balloon (DCB) technology and the role of DCBs in the treatment of coronary and peripheral arterial disease. In addition to clear explanation of how DCBs works, readers will find an enlightening analysis of the mistakes and successes of the past decade and the emergence of the latest delivery systems, which combine a more deliverable device with much improved drug delivery to the vessel wall. The full range of current applications of DCBs are reviewed in detail, drawing on the latest scientific evidence. Due attention is paid to newer devices, with provision of technical insights and documentation of the available clinical data. Ongoing research projects, remaining technical challenges, likely future directions, and reimbursement issues are also carefully considered. This book will be a useful tool for any interventional cardiologist, interventional radiologist, or vascular surgeon who wishes to acquire a deep knowledge of this technology and its application in both coronary and peripheral interventions. |
| dual antiplatelet therapy guidelines 2021: Acute Ischemic Stroke R. Gilberto González, Joshua A. Hirsch, Michael H. Lev, Pamela W. Schaefer, Lee H. Schwamm, 2010-10-05 This updated second edition of Acute Ischemic Stroke: Imaging and Intervention provides a comprehensive account of the state of the art in the diagnosis and treatment of acute ischemic stroke. The basic format of the first edition has been retained, with sections on fundamentals such as pathophysiology and causes, imaging techniques and interventions. However, each chapter has been revised to reflect the important recent progress in advanced neuroimaging and the use of interventional tools. In addition, a new chapter is included on the classification instruments for ischemic stroke and their use in predicting outcomes and therapeutic triage. All of the authors are internationally recognized experts and members of the interdisciplinary stroke team at the Massachusetts General Hospital and Harvard Medical School. The text is supported by numerous informative illustrations, and ease of reference is ensured through the inclusion of suitable tables. This book will serve as a unique source of up-to-date information for neurologists, emergency physicians, radiologists and other health care providers who care for the patient with acute ischemic stroke. |
| dual antiplatelet therapy guidelines 2021: Cancer-Associated Thrombosis Alok A. Khorana, Charles W. Francis, 2007-09-26 Showcasing the expertise of top-tier specialists who contributed to the newly released guidelines for the care of thrombosis in cancer patients, this exciting guide was written and edited by members of the American Society of Clinical Oncology panel, (ASCO), on the prevention and treatment of cancer-associated thrombosis, among others, and provides |
| dual antiplatelet therapy guidelines 2021: Burket's Oral Medicine Lester William Burket, Martin S. Greenberg, Michael Glick, 2003 Presenting the status of the fields of oral medicine and clinical oral pathology, this text also outlines the dentist's role in the management of patients with severe medical problems. It reflects the dramatic alterations in some disease patterns as well as the medical advances, which have made an impact on the field of oral medicine. Focusing on knowledge of the pathogenesis and management of diseases, it stresses new diagnostic techniques as well as new concepts of therapy. Chapter topics include the significant research in the field of facial pain management and the impact in oral medicine of such diseases as asthma, chronic obstructive pulmonary disease and tuberculosis. Also examined is the growing importance of geriatrics in dentistry and the issues of Alzheimer's, Parkinson's disease and elderly patients receiving multiple medications. The book includes a CD-ROM with complete text and illustrations. |
| dual antiplatelet therapy guidelines 2021: Oncologic Critical Care Joseph L. Nates, Kristen J. Price, 2019-10-30 This major reference work is the most comprehensive resource on oncologic critical care. The text reviews all significant aspects of oncologic ICU practices, with a particular focus on challenges encountered in the diagnosis and management of the critically ill cancer patient population. Comprised of over 140 chapters, the text explores such topics as the organization and management of an oncologic ICU, diseases and complications encountered in the oncologic ICU, multidisciplinary care, surgical care, transfusion medicine, special patient populations, critical care procedures, ethics, pain management, and palliative care. Written by worldwide experts in the field, Oncologic Critical Care is a valuable resource for intensivists, advance practice providers, nurses, and other healthcare providers, that will help close significant knowledge and educational gaps within the realm of medical care for critically ill cancer patients. |
| dual antiplatelet therapy guidelines 2021: Antiplatelet Agents Paolo Gresele, Gustav V. R Born, Carlo Patrono, Clive P. Page, 2012-08-23 Antiplatelet therapy is the cornerstone of treatment of ischemic cardiovascular disease and over the last few years spectacular advancements in this field have been recorded. This is the first comprehensive handbook entirely dedicated to all the aspects of antiplatelet therapy. The book is divided into three main sections, pathophysiology, pharmacology and therapy, for a total of 23 chapters. A large group of leading experts from different European countries and from the USA, both from academia and industry, have contributed to the book. Besides a detailed overview on the pharmacology and clinical applications of all the currently used or of the novel antiplatelet agents, innovative approaches (e.g. intracellular signalling as an antiplatelet target, small RNAs as platelet therapeutics, etc.) or unconventional aspects (e.g. pharmacologic modulation of the inflammatory action of platelets are also treated. The book is oriented to both basic investigators and to clinicians involved with research on platelet inhibition or with the clinical use of antiplatelet therapies. |
| dual antiplatelet therapy guidelines 2021: ICD-10-CM Official Guidelines for Coding and Reporting - FY 2021 (October 1, 2020 - September 30, 2021) Department Of Health And Human Services, 2020-09-06 These guidelines have been approved by the four organizations that make up the Cooperating Parties for the ICD-10-CM: the American Hospital Association (AHA), the American Health Information Management Association (AHIMA), CMS, and NCHS. These guidelines are a set of rules that have been developed to accompany and complement the official conventions and instructions provided within the ICD-10-CM itself. The instructions and conventions of the classification take precedence over guidelines. These guidelines are based on the coding and sequencing instructions in the Tabular List and Alphabetic Index of ICD-10-CM, but provide additional instruction. Adherence to these guidelines when assigning ICD-10-CM diagnosis codes is required under the Health Insurance Portability and Accountability Act (HIPAA). The diagnosis codes (Tabular List and Alphabetic Index) have been adopted under HIPAA for all healthcare settings. A joint effort between the healthcare provider and the coder is essential to achieve complete and accurate documentation, code assignment, and reporting of diagnoses and procedures. These guidelines have been developed to assist both the healthcare provider and the coder in identifying those diagnoses that are to be reported. The importance of consistent, complete documentation in the medical record cannot be overemphasized. Without such documentation accurate coding cannot be achieved. The entire record should be reviewed to determine the specific reason for the encounter and the conditions treated. |
| dual antiplatelet therapy guidelines 2021: The ESC Textbook of Thrombosis Raffaele De Caterina, David Moliterno, Steen Kristensen, 2024 The ESC Textbook of Thrombosis is the third iteration of Therapeutic Advances in Thrombosis. Now a new addition to the European Society of Cardiology (ESC) publications portfolio, it is informed by the work of the ESC's Working Group on Thrombosis. Written by internationally renowned experts in the field of thrombosis, the textbook presents an up-to-date and in-depth review of all aspects of thrombosis and antithrombotic therapies. Not only does it reflect contemporary European guidelines from the ESC but also it also summarizes the latest evidence from clinical trials. Covering the topic in great detail with thirty-one chapters, the textbook is split into four sections: Pathophysiology of thrombosis, Clinical pharmacology of antithrombotic drugs, Therapeutic strategies, and Special situations. Appealing to the large community of cardiovascular healthcare specialists in Europe and across the world, the textbook is a must read for cardiologists dealing with acute and chronic coronary syndromes, atrial fibrillation, artificial heart valves and pulmonary embolism. It will also appeal to cardiac surgeons, cardiovascular researchers, and general physicians alike. |
| dual antiplatelet therapy guidelines 2021: Cardiology Update 2022 Vijay Bang, Ashish Deshpande, Vigyan Bang, 2022-11-28 |
| dual antiplatelet therapy guidelines 2021: Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions, An Issue of Interventional Cardiology Clinics Luis Ortega Paz, 2024-09-12 In this issue of Interventional Cardiology Clinics, guest editor Dr. Luis Ortega Paz brings his considerable expertise to the topic of Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions. Top experts in the field discuss regulation of platelet activation and coagulation; genetic determinants of P2Y12 inhibitors and clinical implications; switching P2Y12 receptor inhibiting therapies; high bleeding risk in patients undergoing coronary and structural heart interventions; and much more. - Contains 13 relevant, practice-oriented topics including antithrombotic therapy in atrial fibrillation patients undergoing coronary stenting; antithrombotic therapy in patients undergoing transcatheter aortic valve replacement; antithrombotic therapy in patients undergoing peripheral artery interventions; antiplatelet therapy in women; and more. - Provides in-depth clinical reviews on antiplatelet and anticoagulation therapy in cardiovascular and pulmonary embolism transcatheter interventions, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. |
| dual antiplatelet therapy guidelines 2021: Precision Medicine for Antithrombotic Therapy in Patients after Percutaneous Coronary Interventions Mattia Galli, Francesco Costa, Dominick Angiolillo, 2023-03-31 |
Marvel Rivals Console/Controller Settings Guide 2025
Dec 27, 2024 · Aim Response Curve Type: Determines how your controller responds when you tilt your right analog stick. You have a choice between Dual-Zone (the new default Overwatch curve …
Best armour and augments for Dual Guns + Longsword build
Apr 18, 2025 · Tc did specifically mention blossom dance. And resistances aren't important when using ghost walker/factory, which I assume he is given the dual guns. Yup I want to abuse Ghost …
Conditions for Dual Ultimates? - Dragon Ball: Xenoverse 2
As long as the custom partner has the Dual Ultimate equipped, they will use it every so often and then you can do the input for the second part of the attack no matter what you have equipped. …
Can I dual wield? - The Elder Scrolls IV: Oblivion - GameFAQs
Sep 10, 2007 · At stage 25 of The Path of Dawn quest, it is scripted for no apparent reason for Martin Septim to have a Lesser Staff of Lightning removed from his inventory, even though, …
Character Creation - Icewind Dale: Enhanced Edition ... - GameFAQs
Apr 30, 2021 · For two-class combinations, dual-classing from Fighter is slightly better than multiclassing because dual-classing gives Grand Mastery, more HP and faster level gain. …
Resident Evil: Director's Cut Walkthrough & Guide - GameFAQs
Mar 24, 2024 · The Director's Cut is the first version of the original Resident Evil that I had played and the one I like best. While the Dual Shock edition that followed adds functionality to the …
Differences between original and Dual Shock versions?
My bad, in regards to the Ink Ribbons... to be really specific, in both modes of the original Director's Cut and in Arrange Mode in the Dual Shock version, you get 3 ribbons each pickup. It's only in …
Character Creation - Baldur's Gate: Enhanced Edition ... - GameFAQs
Apr 21, 2024 · Multiclass vs. Dual Class There is a subtle distinction between multiclass characters and dual-class characters. The idea of playing an A / B multiclass character (for example, a …
Ideal build for Rush for the first playthrough
For me I'm just going for a dual-wield build. Probably a ninja if I can get the requirements for it down. I was BR25 at The Fallen on PC and I got Rush to Ninja about halfway through. Now that …
Some suggestions after 20+ hours for those still struggling
Oct 26, 2024 · Dual Gunner (Tech): fire-infused attack; Quadrastrike (Tech): high-BP damage (perfect for United Attack) Heeled Sandals (Legs): allows you to use a special kick attack …
Marvel Rivals Console/Controller Settings Guide 2025
Dec 27, 2024 · Aim Response Curve Type: Determines how your controller responds when you tilt your right analog stick. You have a choice between Dual-Zone (the new default Overwatch curve …
Best armour and augments for Dual Guns + Longsword build
Apr 18, 2025 · Tc did specifically mention blossom dance. And resistances aren't important when using ghost walker/factory, which I assume he is given the dual guns. Yup I want to abuse Ghost …
Conditions for Dual Ultimates? - Dragon Ball: Xenoverse 2
As long as the custom partner has the Dual Ultimate equipped, they will use it every so often and then you can do the input for the second part of the attack no matter what you have equipped. …
Can I dual wield? - The Elder Scrolls IV: Oblivion - GameFAQs
Sep 10, 2007 · At stage 25 of The Path of Dawn quest, it is scripted for no apparent reason for Martin Septim to have a Lesser Staff of Lightning removed from his inventory, even though, …
Character Creation - Icewind Dale: Enhanced Edition ... - GameFAQs
Apr 30, 2021 · For two-class combinations, dual-classing from Fighter is slightly better than multiclassing because dual-classing gives Grand Mastery, more HP and faster level gain. …
Resident Evil: Director's Cut Walkthrough & Guide - GameFAQs
Mar 24, 2024 · The Director's Cut is the first version of the original Resident Evil that I had played and the one I like best. While the Dual Shock edition that followed adds functionality to the …
Differences between original and Dual Shock versions?
My bad, in regards to the Ink Ribbons... to be really specific, in both modes of the original Director's Cut and in Arrange Mode in the Dual Shock version, you get 3 ribbons each pickup. It's only in …
Character Creation - Baldur's Gate: Enhanced Edition ... - GameFAQs
Apr 21, 2024 · Multiclass vs. Dual Class There is a subtle distinction between multiclass characters and dual-class characters. The idea of playing an A / B multiclass character (for example, a …
Ideal build for Rush for the first playthrough
For me I'm just going for a dual-wield build. Probably a ninja if I can get the requirements for it down. I was BR25 at The Fallen on PC and I got Rush to Ninja about halfway through. Now that …
Some suggestions after 20+ hours for those still struggling
Oct 26, 2024 · Dual Gunner (Tech): fire-infused attack; Quadrastrike (Tech): high-BP damage (perfect for United Attack) Heeled Sandals (Legs): allows you to use a special kick attack …
